Public Health at Risk

A US Free Trade Agreement could threaten access to medicines in Thailand

Briefing Paper

Published: Apr 19, 2006

Publication Summary

New stringent drug patent and marketing rules being negotiated in a Free Trade Agreement (FTA) between the US and Thailand would limit competition and reduce access to affordable medicines in Thailand. This would threaten the future of existing successful Thai HIV/AIDS treatment programmes, which rely on inexpensive generic drugs, and thus deprive thousands of people of effective treatment. Oxfam opposes an FTA with intellectual property rules that exceed the standards agreed at the World Trade Organization.

This document is available for download (below) in English, French, Thai, Khmer, Vietnamese, and Indonesian translations.

Public Health at Risk: A US Free Trade Agreement could threaten access to medicines in Thailand (223.4 kB)
US_Thai_FTA_Med_Paper_Thai_final.pdf (556.5 kB)
US_Thai_FTA__Meds_Indonesian_final.pdf (224.9 kB)
US-Thai_FTA__Meds_summary_French_final.pdf (56.2 kB)
Spanish_US_Thai_FTA__Medicines_summary.pdf (59.9 kB)
Vietnamese Translation (591.1 kB)
US_Thai_FTA_and_Meds_Khmer (259.4 kB)
Document Actions
Questions?

Students and researchers

Please contact research@oxfamamerica.org with questions and for help with any Oxfam research materials.

General inquiries

If you have a question or comment about any other Oxfam America publication, or would like to submit a letter to the Editor of OXFAMExchange Magazine, please contact editor@oxfamamerica.org.